One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Decoding the proteomic landscape of inflammatory bowel disease Free
doi : 10.1093/ecco-jcc/jjaf008
Volume 19, Issue 1, January 2025
The power of real-world data: insights into incident IBD populations in the modern era Free
doi : 10.1093/ecco-jcc/jjaf013
Diverse Phenotypes, Consistent Treatment: A Study of 30 997 South Asian and White Inflammatory Bowel Disease Patients Using the UK Inflammatory Bowel Disease BioResource Open Access
doi : 10.1093/ecco-jcc/jjae186
Ulcerative Colitis Severity Classification and Localized Extent (UC-SCALE): An Artificial Intelligence Scoring System for a Spatial Assessment of Disease Severity in Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjae187
Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae191
Artificial intelligence–enabled histology exhibits comparable accuracy to pathologists in assessing histological remission in ulcerative colitis: a systematic review, meta-analysis, and meta-regression Open Access
doi : 10.1093/ecco-jcc/jjae198
Artificial Intelligence-assisted Video Colonoscopy for Disease Monitoring of Ulcerative Colitis: A Prospective Study Open Access
doi : 10.1093/ecco-jcc/jjae080
Preventable Predictive Factors of Post-colonoscopy Colorectal Cancer in Inflammatory Bowel Disease
doi : 10.1093/ecco-jcc/jjae115
Chronic Poor Sleep is Associated with Increased Disease Activity in Patients with Ulcerative Colitis: Prospective Observational Study in Japan
doi : 10.1093/ecco-jcc/jjae116
Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal Mucosa
doi : 10.1093/ecco-jcc/jjae117
The Impact of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation on the Early Development of Intestinal Fibrosis in Crohn’s Disease
doi : 10.1093/ecco-jcc/jjae121
Fecal Calprotectin Diagnostic Level Gradient Along the Small Bowel in Patients With Crohn’s Disease
doi : 10.1093/ecco-jcc/jjae123
Specific Bacterial Co-abundance Groups Are Associated With Inflammatory Status in Patients With Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjae125
HLA-DQA1*05 Associates With Anti-Tumor Necrosis Factor Immunogenicity and Low Adalimumab Trough Concentrations in Inflammatory Bowel Disease Patients From the SERENE Ulcerative Colitis and Crohn’s Disease Studies Open Access
doi : 10.1093/ecco-jcc/jjae129
Anti-TNF nonresponse in ulcerative colitis: correcting for mucosal drug exposure reveals distinct cytokine profiles
doi : 10.1093/ecco-jcc/jjae200
Improvement in serum eosinophilia is observed in clinical responders to ustekinumab but not adalimumab in inflammatory bowel disease Open Access
doi : 10.1093/ecco-jcc/jjaf006
Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis Open Access
doi : 10.1093/ecco-jcc/jjad187
The Natural History of Crohn’s Disease Leading to Intestinal Failure: A Longitudinal Cohort Study from 1973 to 2018
doi : 10.1093/ecco-jcc/jjae114
Changes in Endoscopic Activity and Classification of Lesions With Panenteric Capsule Endoscopy in Patients Treated for Crohn’s Disease—A Prospective Blinded Comparison With Ileocolonoscopy, Fecal Calprotectin, and C-Reactive Protein
doi : 10.1093/ecco-jcc/jjae124
Subcutaneous Infliximab Cutoff Points in Patients With Inflammatory Bowel Disease: Data From the ENEIDA Registry
doi : 10.1093/ecco-jcc/jjae127
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn’s perianal fistulas Open Access
doi : 10.1093/ecco-jcc/jjae199
Inflammatory bowel diseases in the elderly population: epidemiology, long-term disease course, surgery rates, and biological use—data from the Veszprem county cohort between 1977 and 2020 Open Access
doi : 10.1093/ecco-jcc/jjaf003
Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies Open Access
doi : 10.1093/ecco-jcc/jjaf005
Durable remission after ileocolic resection for Crohn’s disease is achievable in selected patients. Long-term results of a prospective multicentric cohort study of the GETAID Chirurgie
doi : 10.1093/ecco-jcc/jjae193
Diagnosing Crohn’s disease in presumed cryptoglandular perianal fistulas: an expert Delphi consensus on early identification of patients at risk of Crohn’s disease in perianal fistulas (PREFAB) Open Access
doi : 10.1093/ecco-jcc/jjaf002
Deconditioning in quiescent Crohn’s disease patients with heightened fatigue perception Open Access
doi : 10.1093/ecco-jcc/jjae194
Multi-omics data integration identifies novel biomarkers and patient subgroups in inflammatory bowel disease Open Access
doi : 10.1093/ecco-jcc/jjae197
Emerging Patterns of Inflammatory Bowel Disease in Sub-Saharan Africa: 175 Cases From an Inflammatory Bowel Disease Network Open Access
doi : 10.1093/ecco-jcc/jjae126
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn’s Disease: A Post-hoc Analysis of the FITZROY Trial Open Access
doi : 10.1093/ecco-jcc/jjae113
Assessment and reporting of extraintestinal manifestations and fatigue in phase 3 inflammatory bowel disease clinical trials
doi : 10.1093/ecco-jcc/jjaf009
Combination of white-light imaging–based and narrow-band imaging–based artificial intelligence models during colonoscopy in patients with ulcerative colitis
doi : 10.1093/ecco-jcc/jjaf014
Corrigendum to: European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation Free
doi : 10.1093/ecco-jcc/jjae195
Corrigendum to: Autophagy Reduces the Degradation and Promotes Membrane Localization of Occludin to Enhance the Intestinal Epithelial Tight Junction Barrier against Paracellular Macromolecule Flux Free
doi : 10.1093/ecco-jcc/jjae196
Corrigendum to: Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal Mucosa Free
doi : 10.1093/ecco-jcc/jjaf004
